PhzA/B Catalyzes the Formation of the Tricycle in Phenazine Biosynthesis
Authors:
- Petra JanningPJPetra Janning
- Matthias MentelMMMatthias Mentel
- Almut GraebschAGAlmut Graebsch
- Rolf BreinbauerRBRolf Breinbauer
- Wolf HillerWHWolf Hiller
- Burkhard CostisellaBCBurkhard Costisella
- Linda S. ThomashowLTLinda S. Thomashow
- Dmitri V. MavrodiDMDmitri V. Mavrodi
- Wulf BlankenfeldtWBWulf Blankenfeldt
- 17 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 130 (50) , 17053-17061
Abstract
Phenazines are redox-active bacterial secondary metabolites that participate in important biological processes such as the generation of toxic reactive oxygen species and the reduction of environmental iron. Their biosynthesis from chorismic acid depends on enzymes encoded by the phz operon, but many details of the pathway remain unclear. It previously was shown that phenazine biosynthesis involves the symmetrical head-to-tail double condensation of two identical amino-cyclohexenone molecules to a tricyclic phenazine precursor. While this key step can proceed spontaneously in vitro, we show here that it is catalyzed by PhzA/B, a small dimeric protein of the Δ5-3-ketosteroid isomerase/nuclear transport factor 2 family, and we reason that this catalysis is required in vivo. Crystal structures in complex with analogues of the substrate and product suggest that PhzA/B accelerates double imine formation by orienting two substrate molecules and by neutralizing the negative charge of tetrahedral intermediates through protonation. HPLC-coupled NMR reveals that the condensation product rearranges further, which is probably important to prevent back-hydrolysis, and may also be catalyzed within the active site of PhzA/B. The rearranged tricyclic product subsequently undergoes oxidative decarboxylation in a metal-independent reaction involving molecular oxygen. This conversion does not seem to require enzymatic catalysis, explaining why phenazine-1-carboxylic acid is a major product even in strains that use phenazine-1,6-dicarboxylic acid as a precursor of strain-specific phenazine derivatives.Keywords
This publication has 28 references indexed in Scilit:
- Pyocyanin Alters Redox Homeostasis and Carbon Flux through Central Metabolic Pathways in Pseudomonas aeruginosa PA14Journal of Bacteriology, 2007
- The phenazine pyocyanin is a terminal signalling factor in the quorum sensing network of Pseudomonas aeruginosaMolecular Microbiology, 2006
- Rethinking 'secondary' metabolism: physiological roles for phenazine antibioticsNature Chemical Biology, 2006
- Infection and inflammation in cystic fibrosis: A short reviewJournal of Cystic Fibrosis, 2005
- Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In VivoThe Journal of Immunology, 2005
- The role of pyocyanin in Pseudomonas aeruginosa infectionTrends in Molecular Medicine, 2004
- Phenazines and Other Redox-Active Antibiotics Promote Microbial Mineral ReductionApplied and Environmental Microbiology, 2004
- Characterization of a novel phenazine antibiotic gene cluster in Erwinia herbicola Eh1087Molecular Microbiology, 2002
- Molecular mechanisms of defense by rhizobacteria against root disease.Proceedings of the National Academy of Sciences, 1995
- Occurrence, Biochemistry and Physiology of Phenazine Pigment Production1986